Ventana Medical Systems
Beth Rayl, Ph.D., is a seasoned professional in the biotechnology and diagnostics fields, currently serving as Senior International Product Manager at Roche since June 2009, where responsibilities include Life Cycle Management of various cytology and histology products and strategies. Prior to Roche, Beth held the position of Director of Marketing, Automation at Third Wave Technologies, focusing on automated solutions for molecular diagnostics after its acquisition by Hologic. Beth's earlier experience includes over a decade at PerkinElmer LAS in various management roles, including Scientific and Marketing Execution Manager and Global Product Leader, where Beth was responsible for product management and profitability. Additionally, Beth served as Field Application Manager for Packard Biosciences in the Americas before its acquisition by PerkinElmer. Educational credentials include a Ph.D. in Molecular Biology and Biochemistry from the University of Illinois Chicago and a Post Doctoral Fellowship in Pediatric Oncology and Pharmacology from Yale University.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.